Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
ZYME US​

Zymeworks Inc.(ZYME US)

$28.22-0.220.77%Ext:$28.83+0.612.17%(Market Closed · 00:00:02 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

SEC Filings

Financials(17)

Expand
  • 10-QQ2ended 30 Jun 20266 Aug
  • 10-QQ1ended 31 Mar 20267 May
  • 10-KFY 2025ended 31 Dec 20252 Mar
  • 10-QQ3ended 30 Sept 20256 Nov 2025
  • 10-QQ2ended 30 Jun 20257 Aug 2025
  • 10-QQ1ended 31 Mar 20258 May 2025
  • 10-KFY 2024ended 31 Dec 20245 Mar 2025
  • 10-QQ3ended 30 Sept 202431 Oct 2024
  • 10-QQ2ended 30 Jun 20241 Aug 2024
  • 10-QQ1ended 31 Mar 20242 May 2024
  • 10-KFY 2023ended 31 Dec 20236 Mar 2024
  • 10-QQ3ended 30 Sept 20237 Nov 2023
  • 10-QQ2ended 30 Jun 202310 Aug 2023
  • 10-QQ1ended 31 Mar 20238 May 2023
  • 10-K/AFY 2022ended 31 Dec 202228 Apr 2023

Events(79)

Expand
  • 8-KEntry into a Material Definitive Agreement23 Oct
  • 8-KZymeworks Completes Acquisition of Theravance Biopharma23 Sep
  • 8-KRegulation FD Disclosure25 Aug
  • 8-KResults of Operations and Financial Condition6 Aug
  • 8-KZymeworks to Acquire Theravance Biopharma, Inc.29 Jun
  • 8-KZymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock14 May
  • 8-KResults of Operations and Financial Condition7 May
  • 8-KZymeworks Appoints Kristin Stafford as Chief Financial Officer1 Apr
  • 8-KZymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing2 Mar
  • 8-KResults of Operations and Financial Condition2 Mar
  • 8-KZymeworks Outlines Strategic Priorities and Outlook for 202612 Jan
  • 8-KSubmission of Matters to a Vote of Security Holders30 Dec 2025
  • 8-KZymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by18 Nov 2025
  • 8-KZymeworks Announces PositiveHERIZON-GEA-01Phase 3 Results Supporting Ziihera®17 Nov 2025
  • 8-KResults of Operations and Financial Condition6 Nov 2025

Insider Ownership(119)

Expand
  • 4Statement of changes in beneficial ownership9 Oct
  • 4Statement of changes in beneficial ownership6 Jul
  • 4Statement of changes in beneficial ownership15 May
  • 3Initial statement of beneficial ownership15 May
  • 4Statement of changes in beneficial ownership10 Apr
  • 4Statement of changes in beneficial ownership10 Apr
  • 3Initial statement of beneficial ownership10 Apr
  • 3Initial statement of beneficial ownership10 Apr
  • 4Statement of changes in beneficial ownership7 Apr
  • 3Initial statement of beneficial ownership7 Apr
  • 3Initial statement of beneficial ownership2 Feb
  • 4Statement of changes in beneficial ownership13 Jan
  • 3Initial statement of beneficial ownership13 Jan
  • 4Statement of changes in beneficial ownership13 Jan
  • 3Initial statement of beneficial ownership13 Jan

Beneficial Ownership(41)

Expand
  • SC 13G/AZymeworks Inc.15 May
  • SC 13GZymeworks Inc.15 Apr
  • SC 13G/AZymeworks Inc.13 Feb
  • SC 13G/AZymeworks Inc.12 Feb
  • SC 13D/AZymeworks Inc.19 Nov 2025
  • SC 13G/AZymeworks Inc.14 Nov 2025
  • SC 13G/AZymeworks Inc.14 Nov 2025
  • SC 13G/AZymeworks Inc.14 Aug 2025
  • SC 13G/AZymeworks Inc.16 Jul 2025
  • SC 13DZymeworks Inc.27 Jun 2025
  • SC 13G/AZymeworks Inc.7 May 2025
  • SC 13D/AZymeworks Inc.8 Apr 2025
  • SC 13D/AZymeworks Inc.17 Mar 2025
  • SC 13D/AZymeworks Inc.18 Feb 2025
  • SC 13G/AZymeworks Inc.14 Feb 2025

Other Ownership(22)

Expand
  • 144Schayowitz Adam9 Oct
  • 144Smith Jeffrey T L6 Mar
  • 144PATTERSON LEONE D17 Feb
  • 144PATTERSON LEONE D13 Feb
  • 144PATTERSON LEONE D12 Jan
  • 144Galbraith Kenneth12 Jan
  • 144Moore Paul Andrew12 Jan
  • 144Hollywood Mark12 Jan
  • 144Smith Jeffrey T L12 Jan
  • 144Smith Jeffrey T L5 Jan
  • 144Galbraith Kenneth5 Jan
  • 144Moore Paul Andrew5 Jan
  • 144Galbraith Kenneth22 Dec 2025
  • 144Miller Derek John Michael24 Nov 2025
  • 144Gallagher Neil21 Nov 2025

Proxies(12)

Expand
  • PRE 14APreliminary proxy statement16 Oct
  • ARSAnnual report to security holders10 Nov 2025
  • DEFA14ADefinitive additional materials10 Nov 2025
  • DEF 14ADefinitive proxy statement10 Nov 2025
  • DEFA14ADefinitive additional materials29 Oct 2024
  • ARSAnnual report to security holders29 Oct 2024
  • DEF 14ADefinitive proxy statement29 Oct 2024
  • ARSAnnual report to security holders26 Oct 2023
  • DEFA14ADefinitive additional materials26 Oct 2023
  • DEF 14ADefinitive proxy statement26 Oct 2023
  • DEF 14ADefinitive proxy statement25 Nov 2022
  • DEFA14ADefinitive additional materials

Registrations(35)

Expand
  • S-8Registration statement (employee benefit plan)2 Mar
  • S-8Registration statement (employee benefit plan)5 Mar 2025
  • S-8Registration statement (employee benefit plan)5 Mar 2025
  • 424B5Prospectus filing (Rule 424(b)(5))2 Aug 2024
  • 424B5Prospectus filing (Rule 424(b)(5))3 May 2024
  • 424B5Prospectus filing (Rule 424(b)(5))3 May 2024
  • S-3ASRAutomatic shelf registration statement (S-3)2 May 2024
  • S-3ASRAutomatic shelf registration statement (S-3)7 Mar 2024
  • S-8Registration statement (employee benefit plan)7 Mar 2024
  • RWRegistration withdrawal request7 Mar 2024
  • S-3Registration statement (primary offering)6 Mar 2024
  • 8-A12B/ARegistration of securities (Section 12(b), amendment)12 Jun 2023
  • 424B5Prospectus filing (Rule 424(b)(5))8 May 2023
  • 424B5Prospectus filing (Rule 424(b)(5))8 May 2023
  • S-8Registration statement (employee benefit plan)7 Mar 2023

Filing Review Correspondence(2)

Expand
  • CORRESPFiling review correspondence30 Aug 2022
  • CORRESPFiling review correspondence19 Aug 2022

SEC Orders And Notices(2)

Expand
  • EFFECTNotice of effectiveness28 Apr 2023
  • EFFECTNotice of effectiveness2 Sep 2022

Exempt Offerings(1)

Expand
  • D06b3 Jan 2024

Other(3)

Expand
  • CERTCERT15 Dec 2022
  • 252515 Dec 2022
  • 8-K12B8-K12B13 Oct 2022

Financials & Metrics

FinancialsChartingShort InterestEmployees